NOW APPROVED

IMCIVREE

IMCIVREE is the first treatment for obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. IMCIVREE has helped people 6 years of age and older lose weight and keep it off.

IMCIVREE should not be used for obesity due to suspected POMC, PCSK1, or LEPR deficiency not confirmed by genetic testing (benign or likely benign result), nor other types of obesity, including those associated with other genetic syndromes and general obesity.

Learn More

IMCIVREE is the first treatment for obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. IMCIVREE has helped people 6 years of age and older lose weight and keep it off.

IMCIVREE should not be used for obesity due to suspected POMC, PCSK1, or LEPR deficiency that is classified as benign or likely benign, nor other types of obesity, including those associated with other genetic syndromes and general obesity.

IMCIVREE treatment

What to know before
starting treatment

Taking IMCIVREE
IMCIVREE treatment resources

Find answers to
common questions

Resources & Support

Important Safety Information

Before using IMCIVREE, tell your healthcare provider about all your medical conditions, including if you:

  • have or have had areas of darkened skin, including skin discoloration (hyperpigmentation).
  • have or have had depression, or suicidal thoughts or behavior.
  • have kidney problems.

What is IMCIVREE?
IMCIVREE is a prescription medicine used in adults and children 6 years of age and older with the genetic